Amarin Corp Plc (AMRN)

[rafunrafun]

Scripts for week ending December 16, 2022

Drug Industry TRx: -0.3% w/w; +6.4% y/y

Vascepa
TRx 65,489; +0.5% (+350) w/w; -19.3% y/y
NRx 30,142; +0.9% (+279) w/w; -19.7% y/y
Ref 35,347; +0.2% (+71) w/w; -18.9% y/y

Fake Vascepa
TRx 44,170; +1.5% (+633) w/w; As % of total V: 40.3%
NRx 20,671; +1.2% (+241) w/w; As % of total V: 40.7%
Ref 23,499; +1.7% (+391) w/w; As % of total V: 39.9%

Fake Vascepa by Manufacturer
Hikma - TRx 15,405; +219 w/w; Generic share 34.9%; Total V share 14.0%
Reddy - TRx 20,497; +535 w/w; Generic share 46.4%; Total V share 18.7%
Apotex - TRx 7,987; -153 w/w; Generic share 18.1%; Total V share 7.3%
Teva - TRx 271; +32 w/w; Generic share 0.6%; Total V share 0.2%

Vascepa + Fake Vascepa
TRx 109,659; +0.9% (+983) w/w; +2.8% y/y
NRx 50,813; +1.0% (+520) w/w; -2.2% y/y
Ref 58,846; +0.8% (+463) w/w; +7.5% y/y

Lovaza (Fake & Brand)
TRx 66,632; +0.9% (+623) w/w; +2.8% y/y
NRx 32,937; +3.0% (+967) w/w; +0.0% y/y
Ref 33,695; -1.0% (-344) w/w; +5.6% y/y